Avem Health Partners, Inc.
FPCG
$1,025.00
$0.000.00%
| Weiss Ratings | FPCG - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Unrated | |||
| Risk Index | Unrated | |||
| Risk Grade | U | |||
| Reward Grade | U | |||
| Rating Factors | FPCG - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | Unrated | |||
| Growth Index | Unrated | |||
| Efficiency Index | Unrated | |||
| Solvency Index | Unrated | |||
| Total Return Index | Unrated | |||
| Volatility Index | Unrated | |||
| Beta / Standard Deviation | FPCG - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | -0.16 | |||
| Price History | FPCG - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 0.00% | |||
| 30-Day Total Return | 0.00% | |||
| 60-Day Total Return | 0.00% | |||
| 90-Day Total Return | 0.00% | |||
| Year to Date Total Return | 0.00% | |||
| 1-Year Total Return | 0.00% | |||
| 2-Year Total Return | 24.27% | |||
| 3-Year Total Return | 51.85% | |||
| 5-Year Total Return | 17,941.02% | |||
| 52-Week High % Change | 0.00% | |||
| 52-Week Low % Change | 0.00% | |||
| Price | FPCG - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $1,025.00 | |||
| 52-Week Low Price | $1,025.00 | |||
| 52-Week Low Price (Date) | Feb 06, 2024 | |||
| 52-Week High Price (Date) | Feb 06, 2024 | |||
| Valuation | FPCG - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 15.17M | |||
| Enterprise Value | -- | |||
| Price/Earnings (TTM) | 15.65 | |||
| Earnings Per Share (TTM) | 65.48 | |||
| Earnings Per Share Growth | -- | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 1.56 | |||
| Price/Book (Q) | 2.46 | |||
| Enterprise Value/Revenue (TTM) | -- | |||
| Price | $1,025.00 | |||
| Enterprise Value/EBITDA (TTM) | -- | |||
| Enterprise Value/EBIT | -- | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | FPCG - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 35.20K | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | $350.57 | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | $350.57 | |||
| Company Info | FPCG - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 405 246 0218 | |||
| Address | 14201 Wireless Way Oklahoma City, OK 73134 | |||
| Website | avemhealth.com | |||
| Country | United States | |||
| Year Founded | 1980 | |||
| Profitability | FPCG - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 41.93% | |||
| Profit Margin | 38.84% | |||
| Management Effectiveness | FPCG - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | 15.63% | |||
| Return on Equity | 68.90% | |||
| Income Statement | FPCG - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 23.11M | |||
| Total Revenue (TTM) | 23.11M | |||
| Revenue Per Share | $656.65 | |||
| Gross Profit (TTM) | 23.11M | |||
| EBITDA (TTM) | 9.70M | |||
| EBIT (TTM) | 9.69M | |||
| Net Income (TTM) | 8.98M | |||
| Net Income Avl. to Common (TTM) | 8.98M | |||
| Total Revenue Growth (Q YOY) | 32.08% | |||
| Earnings Growth (Q YOY) | 57.96% | |||
| EPS Diluted (TTM) | 65.48 | |||
| EPS Diluted Growth (Q YOY) | -- | |||
| Balance Sheet | FPCG - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 1.89M | |||
| Cash Per Share (Q) | $53.69 | |||
| Total Current Assets (Q) | 19.36M | |||
| Total Preferred Equity (Q) | 12.40 | |||
| Total Equity (Q) | 17.38M | |||
| Current Ratio (Q) | 5.056 | |||
| Book Value Per Share (Q) | $415.98 | |||
| Total Assets (Q) | 41.94M | |||
| Total Current Liabilities (Q) | 3.83M | |||
| Total Debt (Q) | 5.82M | |||
| Total Liabilities (Q) | 24.57M | |||
| Total Common Equity (Q) | 4.97M | |||
| Cash Flow | FPCG - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -- | |||
| Cash from Financing (TTM) | -1.81M | |||
| Net Change in Cash (TTM) | 1.70M | |||
| Levered Free Cash Flow (TTM) | 103.60K | |||
| Cash from Operations (TTM) | 3.51M | |||
